Light Medicine – The “Forgotten” Benefits of Ultraviolet Blood Irradiation

Ultraviolet blood irradiation was used with tremendous success in the 1930’s and 1940’s to treat a variety of diseases. However, once antibiotics gained traction UBI fell by the wayside. It may be time to re-visit the “cure that time forgot.”

What is Ultraviolet Blood Irradiation?

Put simply, Ultraviolet Blood Irradiation (UBI for short) involves drawing a small sample of a patient’s blood and placing it in a chamber that exposes it to therapeutic UV wavelengths. The exposed blood is then reintroduced into the patient’s body to elicit an immune system response.

This method was developed in the 1920’s by Emmett Knott. The first treatment on a human was performed in 1928 on a patient with near-fatal sepsis. The patient responded well to the treatment and made a full recovery. There were several reports of successful treatments for a wide range of conditions in the decades that followed, including sepsis, tuberculosis, viral pneumonia, asthma, osteoarthritis, acne vulgaris, peritonitis, and viral hepatitis, to name a few.

How Does Ultraviolet Blood Irradiation Work?

With exposure to UV light, bacteria and viruses in the blood sample absorb five times as much photonic energy as red and white blood cells. This exposure either alters or destroys the infecting agents creating a safe, autogenous “vaccination.”

When the blood is reintroduced into the body, it further activates and directs the immune system to the specific infections the body is attempting to overcome. The net result is the induction of a secondary kill of these infecting agents throughout the entire body. Treating only 35 cc of blood with UBI induces a beneficial systemic response.

UBI at Riordan Clinic

Riordan Clinic has been using Ultraviolet Blood Irradiation as a treatment modality for several years. Our method also includes Ozone as a “first kill” of the infectious agent before treating the patient’s blood sample with the UV light. The ozone treatment uses about 95% Oxygen (O2) and 5% Ozone (O3) that acts as a safe but powerful disinfectant.

The number of treatments needed is determined by variables such as the health of the patient’s immune system, length of time the patient has been ill, and the severity of the disease being treated. UBI can be used clinically as both a SPECIFIC (i.e. psoriasis, lymph cancer) and NON-SPECIFIC (chronic infections, chronic fatigue, auto-immune diseases, etc.) immune-modulating therapy, as noted in several published studies.